Board Meeting on March 11, 2016
Kilitch Drugs India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 11, 2016, inter alia, to consider entering into an Agreement with respect to capital contribution with Arham Neeta Realities LLP,. Outcome of Board Meeting
Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 12, 2016, inter alia, has:- Adopted the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and authorised Mr. Mukund Mehta, Managing Director of the Company to sign, enter and execute the amended Listing Agreement under said Regulations and the same shall be forwarded to BSE & NSE. Financial Results, Limited Review Report for December 31, 2015
Kilitch Drugs India Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20152. Standalone Limited Review for the period ended December 31, 2015 Shareholding for the Period Ended December 31, 2015
Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here Board Meeting on Feb 12, 2016
Kilitch Drugs India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 12, 2016, inter alia, to consider and take on record the following matters:1. Unaudited (Provisional) Financial Result for the quarter ended December 31, 2015 along with the Limited Review Report as submitted by the Statutory Auditors of the Company.... Financial Results & Limited Review for Sept 30, 2015 (Standalone)
Kilitch Drugs India Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2015. Board Intimation for Results & Closure of Trading Window
Kilitch Drugs India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 11, 2015, inter alia, to transact the following business:- To take on record the Unaudited (Provisional) Financial Results for the Quarter and half ended September 30,2015 along with Limited Review Report.Further, as per the Companys Code of Conduct for Prohibition of insider Trading, framed pursuant to the Securities... Kilitch Drugs India forms JV in Ethiopia with local partner
Shares of Kilitch Drugs India were trading a steep 19.97 per cent up at Rs 38.15 per scrip during afternoon session. Formation of Joint Venture
Kilitch Drugs India Ltd has informed BSE that the Company has formed a joint venture in the Republic of Ethiopia with a local party therein to set up a pharmaceutical/nutraceutical manufacturing unit whereby the Company shall be a partner to the tune of 97% and the Ethiopian partner shall hold remaining 3% in the said joint venture. Outcome of AGM
Kilitch Drugs India Ltd has informed BSE that the 23rd Annual General Meeting (AGM) of the Company was held on September 30, 2015.